Market By Technology, Application, Component, End-user, And Geography | Forecast 2019-2027
According to Triton Market Research, the market for 3D cell culture in Latin America is expected to snowball with a CAGR of 12.69% during the projected period between 2019 and 2027.
The countries reviewed in Latin America’s 3D cell culture market include:
• Brazil
• Mexico
• Rest of Latin America
Stem cells and allied applications account for nearly 10-15% of the market for 3D cell culture. Stem cell research has gained significant attention across the world, and thus, even Mexico has taken note of this promising and fast-evolving field. Mexico is focusing on research in regenerative medicine and has been heavily investing in its development. Mexico’s National Council of Science and Technology provides several grants for stem cells. A special sub-program has been charted out to address health-related issues, that support the preservation and transplantation of stem cells, tissues, and organs. Such supportive initiatives by the government are expected to aid the development of Mexico’s 3D cell culture market.
Report scope can be customized per your requirements. Request For Customization
The World Bank states that Uruguay spends only a meager percentage of its GDP on research & development. However, the country has been increasingly taking efforts to rebuild its ability of undertaking scientific and medical research. The successful implementation of these plans calls requires creating several programs to promote research, like the PEDECIBA, which is crucial for the reorganization of research and biology.
Moreover, Chile has realized the potential of stem cell therapies regenerative medicine, and these techniques have gained popularity in the country. Chile is the first country in Latin America to have become a member of the OECD; the country is committed in its efforts to further develop cell and tissue-based therapies and provide training programs, which significantly impact innovation performance, which includes policies for research and development in the country. The increased focus towards research in these countries is thus driving the market for 3D cell culture in Rest of Latin America.
Lonza Group Ltd. supplies pharmaceutical products, agricultural products, as well as, microbial control solutions that fight dangerous viruses, bacteria, and other pathogens. The company primarily caters to microbial control, agriculture, materials science, bioresearch, pharma & biotech, nutrition, and personal care industries. Lonza operates in Europe, Latin America, North America, and Asia, and also has R&D and manufacturing facilities across these regions.
The company’s RAFT 3D Cell Culture System is used for creating 3D models in cancer research, neurobiology, airway research, ocular research, and fibrosis. The company demonstrated steady growth in its financial performance during the review period. The sustained financial performance allows the company to pursue expansion initiatives and provides long-term financial stability. In January 2019, Lonza entered into a collaboration with Japan-based pharma company Takeda to develop solutions for cancer treatment.
Market By Type, Application, E ..
VIEW REPORT
Market By Device Type, Therape ..
VIEW REPORT
Market By Type, Application, T ..
VIEW REPORT
Market By Technology, Applicat ..
VIEW REPORT
Market By Application, Type, E ..
VIEW REPORT
Market by Therapeutics, Diagno ..
VIEW REPORT
Market by Type, Application, E ..
VIEW REPORT1. LATIN
AMERICA 3D CELL CULTURE MARKET – SUMMARY
2. INDUSTRY
OUTLOOK
2.1. MARKET
DEFINITION
2.2. PORTER’S
FIVE FORCES MODEL
2.2.1. THREAT
OF NEW ENTRANTS
2.2.2. THREAT
OF SUBSTITUTE
2.2.3. BARGAINING
POWER OF BUYERS
2.2.4. BARGAINING
POWER OF SUPPLIERS
2.2.5. THREAT
OF COMPETITIVE RIVALRY
2.3. ECONOMIC
TECHNOLOGICAL, AND POLITICAL & LEGAL OUTLOOK
2.4. REGULATORY
OUTLOOK
2.5. KEY
INSIGHT
2.6. MARKET
ATTRACTIVENESS INDEX
2.7. MARKET
DRIVERS
2.7.1. GROWING
CANCER PREVALENCE
2.7.2. HIGH
DEMAND FOR ORGAN TRANSPLANTATION
2.7.3. PROMISING
DEVELOPMENTS USING REGENERATIVE MEDICINE
2.8. MARKET
RESTRAINTS
2.8.1. LACK
OF SKILLED PROFESSIONALS
2.8.2. INCOMPATIBILITIES
OF THE PREFERRED ANALYTICAL TECHNOLOGIES WITH 3D CELL CULTURE
2.9. MARKET
OPPORTUNITIES
2.9.1. INCREASING
USAGE OF 3D CELL CULTURE IN ORGAN TRANSPLANTATION AND DRUG SCREENING
2.9.2. TECHNOLOGICAL
ADVANCEMENT
2.10.
MARKET CHALLENGES
2.10.1.
LACK OF AVAILABILITY OF DATA
FOR RESEARCH ON 3D CELL CULTURE
2.10.2.
CHALLENGES ASSOCIATED WITH 3D
CELL CULTURE IN PERFORMING EXPERIMENTS
3. 3D
CELL CULTURE MARKET OUTLOOK – BY TECHNOLOGY
3.1. SCAFFOLD-BASED
3.1.1. HYDROGELS
3.1.2. POLYMERIC
SCAFFOLDS
3.1.3. MICROPATTERNED
SURFACE MICROPLATES
3.2. SCAFFOLD-FREE
3.2.1. HANGING
DROP MICROPLATES
3.2.2. SPHEROID
MICROPLATES CONTAINING ULTRA-LOW ATTACHMENT (ULA) COATING
3.2.3. MICROFLUIDIC
3D CELL CULTURE
3.2.4. MAGNETIC
LEVITATIONS & 3D BIOPRINTING
3.3. 3D
BIOREACTORS
4. 3D
CELL CULTURE MARKET OUTLOOK – BY APPLICATION
4.1. CANCER
4.2. TISSUE
ENGINEERING & IMMUNOHISTOCHEMISTRY
4.3. DRUG
DEVELOPMENT
4.4. STEM
CELL RESEARCH
4.5. OTHER
APPLICATIONS
5. 3D
CELL CULTURE MARKET OUTLOOK – BY COMPONENT
5.1. MEDIA
5.2. REAGENTS
AND CONSUMABLES
6. 3D
CELL CULTURE MARKET OUTLOOK – BY END-USER
6.1. BIOTECHNOLOGY
AND PHARMACEUTICAL ORGANIZATIONS
6.2. RESEARCH
LABORATORIES AND INSTITUTES
6.3. HOSPITALS
AND DIAGNOSTIC CENTERS
6.4. OTHER
END-USERS
7. 3D
CELL CULTURE MARKET – REGIONAL OUTLOOK
7.1. LATIN
AMERICA
7.1.1. COUNTRY
ANALYSIS
7.1.1.1. BRAZIL
7.1.1.2. MEXICO
7.1.1.3. REST
OF LATIN AMERICA
8. COMPANY
PROFILES
8.1. BECTON
DICKINSON AND COMPANY
8.2. TECAN
GROUP LTD.
8.3. PROMOCELL
GMBH
8.4. CORNING
INC.
8.5. NANO3D
BIOSCIENCES, INC.
8.6. 3D
BIOTEK, LLC
8.7. MERCK
KGAA
8.8. EMULATE
8.9. THERMO
FISHER SCIENTIFIC, INC.
8.10.
GE HEALTHCARE
8.11.
INSPHERO
8.12.
LONZA GROUP AG
8.13.
VWR CORPORATION
8.14.
SYNTHECON, INCORPORATED
9. RESEARCH
METHODOLOGY & SCOPE
9.1. RESEARCH
SCOPE & DELIVERABLES
9.1.1. OBJECTIVES
OF STUDY
9.1.2. SCOPE
OF STUDY
9.2. SOURCES
OF DATA
9.2.1. PRIMARY
DATA SOURCES
9.2.2. SECONDARY
DATA SOURCES
9.3. RESEARCH
METHODOLOGY
9.3.1. EVALUATION
OF PROPOSED MARKET
9.3.2. IDENTIFICATION
OF DATA SOURCES
9.3.3. ASSESSMENT
OF MARKET DETERMINANTS
9.3.4. DATA
COLLECTION
9.3.5. DATA
VALIDATION & ANALYSIS
TABLE 1 LATIN AMERICA 3D CELL CULTURE MARKET
2019-2027 ($ MILLION)
TABLE 2 LATIN AMERICA 3D CELL CULTURE MARKET BY
TECHNOLOGY 2019-2027 ($ MILLION)
TABLE 3 LATIN AMERICA SCAFFOLD-BASED MARKET BY
TYPE 2019-2027 ($ MILLION)
TABLE 4 LATIN AMERICA SCAFFOLD-FREE MARKET BY
TYPE 2019-2027 ($ MILLION)
TABLE 5 LATIN AMERICA 3D CELL CULTURE MARKET BY
APPLICATION 2019-2027 ($ MILLION)
TABLE 6 LATIN AMERICA 3D CELL CULTURE MARKET BY
COMPONENT 2019-2027 ($ MILLION)
TABLE 7 USAGE OF MEDIA IN DIFFERENT STAGES OF
ORGANOIDS FORMATION
TABLE 8 LATIN AMERICA 3D CELL CULTURE MARKET BY
END-USER 2019-2027 ($ MILLION)
TABLE 9 LATIN AMERICA 3D CELL CULTURE MARKET BY
COUNTRY 2019-2027 ($ MILLION)
FIGURE 1 LATIN AMERICA 3D CELL CULTURE MARKET
2019-2027 ($ MILLION)
FIGURE 2 LATIN AMERICA 3D CELL CULTURE MARKET BY
SCAFFOLD-BASED 2019-2027 ($ MILLION)
FIGURE 3 LATIN AMERICA 3D CELL CULTURE MARKET BY
HYDROGELS 2019-2027 ($ MILLION)
FIGURE 4 LATIN AMERICA 3D CELL CULTURE MARKET BY
POLYMERIC SCAFFOLDS 2019-2027 ($ MILLION)
FIGURE 5 LATIN AMERICA 3D CELL CULTURE MARKET BY
MICROPATTERNED SURFACE MICROPLATES 2019-2027 ($ MILLION)
FIGURE 6 LATIN AMERICA 3D CELL CULTURE MARKET BY
SCAFFOLD-FREE 2019-2027 ($ MILLION)
FIGURE 7 LATIN AMERICA 3D CELL CULTURE MARKET BY
HANGING DROP MICROPLATES 2019-2027 ($ MILLION)
FIGURE 8 LATIN AMERICA 3D CELL CULTURE MARKET BY
SPHEROID MICROPLATES CONTAINING ULTRA-LOW ATTACHMENT (ULA) COATING 2019-2027 ($
MILLION)
FIGURE 9 LATIN AMERICA 3D CELL CULTURE MARKET BY
MICROFLUIDIC 3D CELL CULTURE 2019-2027 ($ MILLION)
FIGURE 10 LATIN AMERICA 3D CELL CULTURE MARKET BY
MAGNETIC LEVITATIONS & 3D BIOPRINTING 2019-2027 ($ MILLION)
FIGURE 11 LATIN AMERICA 3D CELL CULTURE MARKET BY 3D
BIOREACTORS 2019-2027 ($ MILLION)
FIGURE 12 LATIN AMERICA 3D CELL CULTURE MARKET BY
CANCER 2019-2027 ($ MILLION)
FIGURE 13 LATIN AMERICA 3D CELL CULTURE MARKET BY
TISSUE ENGINEERING & IMMUNOHISTOCHEMISTRY 2019-2027 ($ MILLION)
FIGURE 14 LATIN AMERICA 3D CELL CULTURE MARKET BY DRUG
DEVELOPMENT 2019-2027 ($ MILLION)
FIGURE 15 LATIN AMERICA 3D CELL CULTURE MARKET BY STEM
CELL RESEARCH 2019-2027 ($ MILLION)
FIGURE 16 LATIN AMERICA 3D CELL CULTURE MARKET BY OTHER
APPLICATIONS 2019-2027 ($ MILLION)
FIGURE 17 LATIN AMERICA 3D CELL CULTURE MARKET BY MEDIA
2019-2027 ($ MILLION)
FIGURE 18 LATIN AMERICA 3D CELL CULTURE MARKET BY
REAGENTS AND CONSUMABLES 2019-2027 ($ MILLION)
FIGURE 19 LATIN AMERICA 3D CELL CULTURE MARKET BY
BIOTECHNOLOGY AND PHARMACEUTICAL ORGANIZATIONS 2019-2027 ($ MILLION)
FIGURE 20 LATIN AMERICA 3D CELL CULTURE MARKET BY
RESEARCH LABORATORIES AND INSTITUTES 2019-2027 ($ MILLION)
FIGURE 21 LATIN AMERICA 3D CELL CULTURE MARKET BY
HOSPITALS AND DIAGNOSTIC CENTERS 2019-2027 ($ MILLION)
FIGURE 22 LATIN AMERICA 3D CELL CULTURE MARKET BY OTHER
END-USERS 2019-2027 ($ MILLION)
FIGURE 23 BRAZIL 3D CELL CULTURE MARKET 2019-2027 ($
MILLION)
FIGURE 24 MEXICO 3D CELL CULTURE MARKET 2019-2027 ($
MILLION)
FIGURE 25 REST OF LATIN AMERICA 3D CELL CULTURE MARKET
2019-2027 ($ MILLION)